Mental Health Intervention in Childhood Epilepsy (MICE)
Evidence for a new psychological treatment for children with epilepsy has been published in The Lancet.
News and blogs
Mental wellbeing and learning impact now included in NICE epilepsy quality standard
Young Epilepsy has welcomed a new quality standard for epilepsy care that say children and young people should be asked about their mental wellbeing and learning at their epilepsy appointments.
New valproate measures to begin in January 2024
The medicines regulator has asked healthcare organisations to plan for new measures related to the anti-seizure medication valproate. These changes will start to be rolled out from January 2024.
What is 'Transition' and what can I expect?
What happens when you transition from paediatric to adult epilepsy care?
Epilepsy12 report on children’s epilepsy care
The latest figures from the Royal College of Paediatrics and Child Health (RCPCH) show that epilepsy care for children is improving, but access to services still varies greatly.
SUDEP Action & Young Epilepsy team up to create an epilepsy risk Checklist for children
SUDEP Action and Cornwall Partnership NHS Foundation Trust are collaborating with Young Epilepsy to create a paediatric version of the SUDEP and Seizure Safety Checklist. The award-winning Checklist, which launched in 2015, supports health professionals in discussing epilepsy mortality risks and SUDEP (Sudden Unexpected Death in Epilepsy) with their patients (aged 16+).
Public Statement from Coalition of Epilepsy Organisations
Young Epilepsy is joining with other organisations from the epilepsy community to call for a review of proposals that could have an impact on access to the anti-seizure medication valproate.
Too many women unaware of the risks linked to epilepsy medication in pregnancy
Epilepsy Medications in Pregnancy Survey Report
NHS to offer new laser surgery for focal epilepsy
NHS to offer new laser surgery for focal epilepsy NHS England has announced it will offer a new type of laser treatment for children and adults with uncontrolled focal seizures.